ALC:NYSE
Alcon AG
$75.26
arrow_upward
+1.55%(+1.15) 1D
$75.26
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Nob 18, 4:00:03 PM GMT-5 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ALC...
Buksan
$73.41
Mataas
$75.52
Mababa
$73.34
Mkt. cap
31.18B
Avg. na dami
2.23M
Dami
4.77M
Mataas nang 52-wk
$87.64
Mababa nang 52-wk
$61.84
Beta
0.87
Mga natitirang share
480.40M
Bilang ng mga empleyado
25K
Buksan
$73.41
Mataas
$75.52
Mababa
$73.34
Mkt. cap
31.18B
Avg. na dami
2.23M
Dami
4.77M
Mataas nang 52-wk
$87.64
Mababa nang 52-wk
$61.84
Beta
0.87
Mga natitirang share
480.40M
Bilang ng mga empleyado
25K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Zacks
·
18 oras ang nakalipas
What Drove Glaukos Stock's 48% Rally Since the End of September?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Tungkol sa Alcon AG
CEODavid J. Endicott
Mga Empleyado25K
Itinatag1945
HeadquartersHinebra, Geneva, Switzerland
SektorHealth Care
Industriya-
Websitealcon.com